Royalty Pharma Plc (RPRX : NASDAQ)
Common Stock
$58.99
USD
+2.42 (4.28%)
Last updated: 2026-10-14
Follow RPRX
RPRX
Royalty Pharma Plc
WealthAwesomePerformance
1 Day
+4.28%
1 Week
+3.93%
1 Month
-0.10%
YTD
+53.89%
Key Statistics
Market Cap
$32.69B
52W High
$64.38
52W Low
$35.23
P/E Ratio
30.09
50 Day MA
$59.15
200 Day MA
$51.63
Beta
0.41
Dividend Yield
1.57%
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 10/14/2026 | $56.93 | $59.08 | $56.78 | $58.99 | $58.99 | 2,757,530 |
| 10/13/2026 | $57.70 | $57.97 | $56.42 | $56.57 | $56.57 | 3,380,236 |
| 10/12/2026 | $57.04 | $57.92 | $56.85 | $57.78 | $57.78 | 2,163,051 |
| 10/9/2026 | $56.03 | $57.08 | $55.72 | $56.93 | $56.93 | 2,882,000 |
| 10/8/2026 | $56.57 | $56.71 | $55.13 | $56.21 | $56.21 | 2,540,314 |
| 10/7/2026 | $56.60 | $57.16 | $56.41 | $56.76 | $56.76 | 3,286,730 |
| 10/6/2026 | $56.66 | $57.13 | $56.04 | $56.44 | $56.44 | 2,434,244 |
| 10/5/2026 | $57.10 | $57.25 | $56.01 | $56.66 | $56.66 | 3,770,322 |
| 10/2/2026 | $57.63 | $57.91 | $56.96 | $57.16 | $57.16 | 2,229,500 |
| 10/1/2026 | $58.36 | $58.40 | $57.22 | $57.63 | $57.63 | 3,245,200 |
Analyst Price Targets
Based on 8 analysts covering RPRX · as of Oct 8, 2026
Wall Street analysts forecast RPRX stock price to rise 10.8% over the next 12 months.
Consensus
Strong Buy4.50 / 5.00
Avg. Target
US$65.38
+10.8% Upside
Previously US$65.13 on Oct 5, 2026
Current Price
US$58.99
Last close
Analyst Breakdown (8 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on RPRX's historical volatility
30-Day Vol
26.0%
Annualized
90-Day Vol
25.3%
Annualized
Trend (90d)
+5.8%
Annualized drift
90d Mean
US$60.22
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$59.40 | US$54.30 – US$64.97 |
| 60 trading days | US$59.81 | US$52.68 – US$67.90 |
| 90 trading days | US$60.22 | US$51.55 – US$70.34 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Royalty Pharma Plc
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company has research and development funding collaboration to advance the development of JNJ-4804, an investigational medicine for autoimmune diseases. The company was founded in 1996 and is based in New York, New York.
Financials
- Revenue (TTM)
- $2.54B
- EBITDA
- $1.56B
- Profit Margin
- 32.02%
- ROE (TTM)
- 13.97%
- EPS (Diluted)
- 1.88
- Book Value
- 15.33
Classification
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About RPRX.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| NVNI | Nvni Group Limited Ordinary Shares | $0.53 | +382.56% |
| HVII | Hennessy Capital Investment Corp. VII Ordinary Shares | $4.46 | +150.56% |
| SOBR | Sobr Safe Inc | $0.08 | +94.88% |
| GLND | Greenland Energy Company Common Stock | $3.90 | +76.47% |
| TGL | Treasure Global Inc. | $0.45 | +61.87% |
| NIVF | NewGenIvf Group Limited Class A Ordinary Shares | $0.29 | +50.20% |
| CRANR | Crane Harbor Acquisition Corp. II Rights | $0.16 | +45.47% |
| HCICR | Hennessy Capital Investment Corp. VIII Share Rights | $0.12 | +41.53% |
RPRX.US news timeline
2 articles covering RPRX.US, most recent first
Latest